T1	p 43 84	early-stage diabetic nephropathy patients
T2	p 320 354	Type 2 diabetic patients ( N.=57 )
T3	p 450 479	Diabetic nephropathy patients
T4	p 841 849	diabetic
T5	p 961 969	diabetic
T6	p 1350 1383	type 2 diabetes mellitus patients
T7	p 1438 1446	patients
T8	i 248 271	thiamine ( vitamin B1 )
T9	i 276 301	pyridoxine ( vitamin B6 )
T10	i 505 507	B6
T11	i 536 541	B1+B6
T12	i 1066 1071	B1+B6
T13	i 1075 1077	B6
T14	i 1083 1085	B6
T15	i 1159 1164	B1+B6
T16	i 1168 1170	B6
T17	i 1477 1482	B1+B6
T18	i 1486 1488	B6
T19	o 6 39	Plasma AGE-peptides and C-peptide
T20	o 163 193	circulatory AGE-peptide levels
T21	o 653 784	glucose , HbA1c , triglyceride , cholesterol , insulin , C-peptide , thiamine pyrophosphate , pyridoxal phosphate and AGE- peptides
T22	o 809 821	AGE-peptides
T23	o 931 943	AGE-peptides
T24	o 1139 1144	HbA1c
T25	o 1208 1217	C-peptide
T26	o 1285 1304	plasma AGE-peptides
T27	o 1529 1541	AGE-peptides
T28	o 1608 1617	C-peptide